Drug Pipeline

Imlunestrant Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
1
Recruiting
1
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-23 NCT07287098
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen…
Trial sites expanded: 42 -> 60 locations
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05514054 A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early… Breast Neoplasms Active, Not Recruiting
Phase 2
NCT07287098 A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen… Breast Neoplasms Not Yet Recruiting
Phase 1/2
NCT05768139 First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other… Breast Cancer Recruiting
Phase 1
NCT05509790 A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer Breast Neoplasms Active, Not Recruiting
NCT05307705 A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors Breast Cancer Active, Not Recruiting
Sponsors Running Imlunestrant Trials
Disease Areas
Get alerts when Imlunestrant trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free